Correlation Between Microsoft and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Microsoft and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Seres Therapeutics, you can compare the effects of market volatilities on Microsoft and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Seres Therapeutics.
Diversification Opportunities for Microsoft and Seres Therapeutics
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Microsoft and Seres is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Microsoft i.e., Microsoft and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Microsoft and Seres Therapeutics
Given the investment horizon of 90 days Microsoft is expected to generate 6.22 times less return on investment than Seres Therapeutics. But when comparing it to its historical volatility, Microsoft is 9.17 times less risky than Seres Therapeutics. It trades about 0.28 of its potential returns per unit of risk. Seres Therapeutics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 61.00 in Seres Therapeutics on September 13, 2024 and sell it today you would earn a total of 23.00 from holding Seres Therapeutics or generate 37.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Microsoft vs. Seres Therapeutics
Performance |
| Timeline |
| Microsoft |
| Seres Therapeutics |
Microsoft and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Seres Therapeutics
The main advantage of trading using opposite Microsoft and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Block Inc | Microsoft vs. Adobe Systems Incorporated |
| Seres Therapeutics vs. Perseus Mining Limited | Seres Therapeutics vs. SOUTHWEST AIRLINES | Seres Therapeutics vs. DISTRICT METALS | Seres Therapeutics vs. CHINA TONTINE WINES |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |